Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000080255-26-000673·PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Schedule 13G ownership disclosure
Pacific Biosciences of California Inc
COMMON STOCK · CUSIP: 69404D108
Event date: 2026-10-31
- Filing-level shares
- 33,445,993
- Percent of class
- 10.8%
- T. Rowe Price Associates, Inc.
Shares: 33,445,993 · Class: 10.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-26-000673
- Form type
- SCHEDULE 13G
- Filer
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- CIK
- CIK 1299130
- Filed
- Nov 06, 2026
- Reporting period
- Oct 31, 2026
- Description
- Schedule 13G beneficial ownership